U & I Pharmaceuticals, Ltd.

Rajendra N Kankan

Yusuf Khwaja Hamied

Dharmaraj R Rao

Pharmaceutical compositions containing Form III, Form IV, Form V olanzapine and/or pharmaceutically acceptable salts thereof. The pharmaceutical compositions are useful for the treatment of psychotic conditions, mild anxiety and gastrointestinal conditions. In particular, the compositions are useful for treating schizophrenia and related disorders, acute mania, Bipolar I Disorder, psychotic mood disorder and psychosis in patients with Alzheimer's disease.

Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof

The invention provides three new polymorphic forms of 2-methyl-4-&lsqb;4-methyl-1-piperazinyl&rsqb;-10H-thieno&lsqb;2,3b&rsqb;&lsqb;1,5&rsqb;benzodiazepine (Olanzapine) (Formula A), the process for preparing the new polymorphs and pharmaceutical compositions containing the polymorphs. The new polymorphic forms of olanzapine are useful for the treatment of psychotic conditions, mild anxiety and gastrointestinal conditions.

Growing community of inventors

Mah, India

Rajendra N Kankan